Lilly to Separate Elanco Animal Health with Initial Public Offering

Go back to Lilly to Separate Elanco Animal Health with Initial Public Offering

Lilly (LLY) Tops Q2 EPS by 20c

July 24, 2018 6:26 AM EDT

Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.50, $0.20 better than the analyst estimate of $1.30. Revenue for the quarter came in at $6.36 billion versus the consensus estimate of $6.05 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $5.40-$5.50, versus the... More